OKYO Pharma ’s Post

Futura Medical shares rise on $5m US milestone payment #AIM #OTC #FUM #FAMDF. Futura Medical PLC (AIM:FUM, OTC:FAMDF) shares rose in early trading after the company secured a $5 million milestone payment following the US launch of its erectile dysfunction gel, Eroxon. The payment was triggered as distribution partner Haleon began fulfilling online pre-orders and making the product available in US retail stores. Eroxon is the first over-the-counter treatment for erectile dysfunction to be sold in the US, and Futura expects to receive the payment soon. In the first hour of trading the stock was up a penny at 33.55p. Stifel reckons peak Eroxon sales will be... http://ow.ly/flzx105La3I

SPAC Feed: Swiftmerge Acquisition in an 8-K said it terminated a merger agreement with HDL Therapeutucs. The decision was mutual and no… - https://lnkd.in/edYKSuTV #SPACs #SPACNews #SPAC #IPO #markets #news #capitalmarkets #trends #goingpublic #finance #business

Zenith Drugs SME IPO's Grey Market Premium, at ₹7 as of Feb 17, 2024, the price band of ₹75-79 per share. The IPO, featuring a lot size of 1600 shares, is open for subscription from February 19 to February 22, 2024. https://lnkd.in/gnHj6mVk #smeipo #SmallCapIPO #ipoinvesting #stockmarkets #investmentopportunity #SMEListing #StartupIPO #ipoalert #SMEExchange #IPOInvestment

Thoughts on this? >> Avantor sells off CRO for $650M to private equity firm >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #healthcare #biotech #productmarketing #pharma #pharmaceutical

Thoughts on this? >> ROVI teases acquisition offers for its CDMO unit potentially worth €2B to €3B >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #biotech #productmarketing #pharmaceutical #pharma #healthcare

Thoughts on this? >> Avantor sells off CRO for $650M to private equity firm >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #productmarketing #biotech #healthcare #pharma #pharmaceutical

Futura Medical PLC (AIM:FUM, OTC:FAMDF) shares rose 3% in early trading after the company secured a $5 million milestone payment following the US launch of its erectile dysfunction gel, Eroxon. The payment was triggered as distribution partner Haleon began fulfilling online pre-orders and making the product available in US retail stores. Eroxon is the first over-the-counter treatment for erectile dysfunction to be sold in the U.S., and Futura expects to receive the payment soon. In the first hour of trading the stock was up a penny at 33.55p. Stifel reckons peak Eroxon sales will be £176 million, valuing the US opportunity alone at around 100p a share. "We continue to see Futura as an undervalued story with significant upside potential, with the prospect of US royalties generating strong operational leverage given a largely fixed existing cost base," the American bank said. More at #Proactive #ProactiveInvestors http://ow.ly/flzx105La3I

#AEMD - Why Arcutis Biotherapeutics Shares Are Trading Higher By 29 Here Are 20 Stocks Moving Premarket Benzinga Shares of Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) rose sharply in today's pre-market trading after the company reported better-than-expect...

Zenith Drugs IPO consists of a fresh issue of 51,48,800 shares aggregating to INR 40.68 crores. The company plans to utilize net proceeds for new unit machinery, block upgrades, working capital, and general purposes. https://lnkd.in/g3xWub-4 #ipo #iponews #fresh #newipo #financialnews #stockmarket #marketentry #newlisting #publicoffering #capitalmarket #investoralert #marketbuzz

I would like to discuss the issues on the November 26 Nikkei Shimbun article, "MBOs to Top 1 Trillion Yen in 2023, Taisho Pharmaceutical and Benesse Following in Succession."